Zavain Dar invests at the intersection and union of cutting-edge biotech and software. He has led Lux’s investments in Primer, a machine intelligence startup; Clarifai, which democratizes cutting edge deep neural networks; Auransa, which is developing novel medicines based on computational insight applied to genomic data; Recursion which uses automation and deep learning to develop drugs for rare diseases; Tempo Automation, which applies software and automation to electronics manufacturing; Rigetti Computing, which is fabricating some of the fastest quantum chips in the world; Braid, which is bringing AI to medical diagnostics; Visor, which aims to simplify tax preparation; Computable Labs, which is building a decentralized data marketplace; Cryptonumerics, a data control company acquired by Snowflake Computing; The Stacks Foundation, which is making Bitcoin programmable; Runway, which is putting machine learning tools into the hands of creators; LabGenius, a protein drug discovery company; Anagenex, a drug discovery company leveraging DNA encoded libraries; Hugging Face, an open-source company democratizing Natural Language Processing; Dyno Therapeutics, an AI-powered gene therapy company; and Thrive Earlier Detection, an early cancer detection company that Exact Sciences agreed to acquire for $2.15 billion in 2020.
Thank you for listening!
BIOS (@BIOS_Community) unites a community of Life Science innovators dedicated to driving patient impact. Alix Ventures (@AlixVentures) is a San Francisco based venture capital firm supporting early stage Life Science startups engineering biology to create radical advances in human health.
Remember Everything You Learn from Podcasts
